| api products | edmf | cep | usa dmf | canada dmf | who | nmpa |
|---|---|---|---|---|---|---|
| abiraterone acetate | √ | √ | √ | √ | ||
| brivaracetam | √ | √ | mar.2022 | |||
| enzalutamide | √ | √ | √ | |||
| eplerenone | √ | √ | √ | √ | ||
| drospirenone | ||||||
| dydrogesterone | √ | √ | ||||
| budesonide | ||||||
| fluticasone propionate | √ | √ | √ | √ | ||
| fluticasone furoate | √ | √ | ||||
| mometasone furoate | √ | √ | √ | |||
| pregabalin | √ | √ | √ | √ | ||
|
tdf (tenofovir disoproxil fumarate) |
√ | √ | √ | √ | ||
|
taf (tenofovir alafenamide hemifumarate) |
√ | √ | √ |
※ disclaimer:
products protected by valid patents in this list are for laboratory analytical/research purposes only and are not offered for sale in countries or area where the sale of such products constitutes a patent infringement. any liability is at buyer's risk.